These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37108090)

  • 1. Increased Immunoglobulin Gamma-3 Chain C in the Serum, Saliva, and Urine of Patients with Systemic Lupus Erythematosus.
    Jung JY; Kim JW; Lee SW; Baek WY; Kim HA; Suh CH
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary Immunoglobulin Gamma-3 Chain C Is a Promising Noninvasive Biomarker for Systemic Lupus Erythematosus.
    Jung JY; Nam JY; Ryu KS; Son IO; Shin JH; Baek WY; Kim HA; Suh CH
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100A8 in Serum, Urine, and Saliva as a Potential Biomarker for Systemic Lupus Erythematosus.
    Kim JW; Jung JY; Lee SW; Baek WY; Kim HA; Suh CH
    Front Immunol; 2022; 13():886209. PubMed ID: 35529863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary angiostatin, CXCL4 and VCAM-1 as biomarkers of lupus nephritis.
    Mok CC; Soliman S; Ho LY; Mohamed FA; Mohamed FI; Mohan C
    Arthritis Res Ther; 2018 Jan; 20(1):6. PubMed ID: 29325582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validity of immunoglobulin-binding protein 1 as a biomarker for lupus nephritis.
    Ebaid AM; Ezzeldin N; Abdelhady EI; Mohammed HA; Abdallah AL
    Lupus; 2023 Jan; 32(1):101-110. PubMed ID: 36418233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory markers in saliva and urine reflect disease activity in patients with systemic lupus erythematosus.
    Ruacho G; Lira-Junior R; Gunnarsson I; Svenungsson E; Boström EA
    Lupus Sci Med; 2022 Mar; 9(1):. PubMed ID: 35246487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary lipocalin-2 is associated with renal disease activity in human lupus nephritis.
    Pitashny M; Schwartz N; Qing X; Hojaili B; Aranow C; Mackay M; Putterman C
    Arthritis Rheum; 2007 Jun; 56(6):1894-903. PubMed ID: 17530720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urine β2-microglobulin is associated with clinical disease activity and renal involvement in female patients with systemic lupus erythematosus.
    Choe JY; Park SH; Kim SK
    Lupus; 2014 Dec; 23(14):1486-93. PubMed ID: 25124677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship of serum 25- hydroxy vitamin D and systemic lupus erythematosus].
    Zou JM; Wu LJ; Luo CN; Shi YM; Wu X
    Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Oct; 53(5):938-941. PubMed ID: 34650298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentraxin 3 Is Closely Associated With Tubulointerstitial Injury in Lupus Nephritis: A Large Multicenter Cross-Sectional Study.
    Pang Y; Tan Y; Li Y; Zhang J; Guo Y; Guo Z; Zhang C; Yu F; Zhao MH
    Medicine (Baltimore); 2016 Jan; 95(3):e2520. PubMed ID: 26817892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokine CXCL1 as a potential marker of disease activity in systemic lupus erythematosus.
    Zeng Y; Lin Q; Yu L; Wang X; Lin Y; Zhang Y; Yan S; Lu X; Li Y; Li W; Xiao Y
    BMC Immunol; 2021 Dec; 22(1):82. PubMed ID: 34961474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum and Urinary Interferon-Gamma-Inducible Protein 10 in Lupus Nephritis.
    El-Gohary A; Hegazy A; Abbas M; Kamel N; Nasef SI
    J Clin Lab Anal; 2016 Nov; 30(6):1135-1138. PubMed ID: 27184880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
    Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
    Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated serum levels of syndecan-1 are associated with renal involvement in patients with systemic lupus erythematosus.
    Kim KJ; Kim JY; Baek IW; Kim WU; Cho CS
    J Rheumatol; 2015 Feb; 42(2):202-9. PubMed ID: 25512478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil to lymphocyte and platelet to lymphocyte ratios in systemic lupus erythematosus: Relation with disease activity and lupus nephritis.
    Soliman WM; Sherif NM; Ghanima IM; El-Badawy MA
    Reumatol Clin (Engl Ed); 2020; 16(4):255-261. PubMed ID: 30166230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-dsDNA, anti-nucleosome, anti-C1q, and anti-histone antibodies as markers of active lupus nephritis and systemic lupus erythematosus disease activity.
    Shang X; Ren L; Sun G; Yu T; Yao Y; Wang L; Liu F; Zhang L; He X; Liu M
    Immun Inflamm Dis; 2021 Jun; 9(2):407-418. PubMed ID: 33470559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement degradation product C3d in urine: marker of lupus nephritis.
    Negi VS; Aggarwal A; Dayal R; Naik S; Misra R
    J Rheumatol; 2000 Feb; 27(2):380-3. PubMed ID: 10685801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of leukocyte CR1 gene transcription with the disease severity and renal involvement in systemic lupus erythematosus.
    Verma J; Arora V; Marwaha V; Kumar A; Das N
    Lupus; 2005; 14(4):273-9. PubMed ID: 15864913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary podocyte microparticles are associated with disease activity and renal injury in systemic lupus erythematosus.
    Lu J; Hu ZB; Chen PP; Lu CC; Zhang JX; Li XQ; Yuan BY; Huang SJ; Ma KL
    BMC Nephrol; 2019 Aug; 20(1):303. PubMed ID: 31382919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum interleukin-2 receptor
    Tian JY; Zhang X; Cheng G; Liu QH; Wang SY; He J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 53(6):1083-1087. PubMed ID: 34916686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.